Related references
Note: Only part of the references are listed.The effect of valsartan and nebivolol treatment on ADMA and pentraxin-3 levels in hypertensive patients
Adem Parlak et al.
MEDICAL HYPOTHESES (2012)
Inflamación y apoptosis en la hipertensión arterial. Importancia de la extensión de la lesión de órgano diana
Pedro Morillas et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2012)
Suppressive Effects of Valsartan on Microalbuminuria and CRP in Patients with Metabolic Syndrome (Val-Mets)
Tetsuro Shishido et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2011)
Inflammation, Immunity, and Hypertension
David G. Harrison et al.
HYPERTENSION (2011)
Combined Therapy with Renin-Angiotensin System and Calcium Channel Blockers in Type 2 Diabetic Hypertensive Patients with Proteinuria: Effects on Soluble TWEAK, PTX3, and Flow-Mediated Dilation
Mahmut Ilker Yilmaz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients
Rahmi Yilmaz et al.
RENAL FAILURE (2010)
Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension
Yoshitaka Hirooka et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis
Jose L. Martin-Ventura et al.
KIDNEY INTERNATIONAL (2008)
Plasma pentraxin 3 in patients with chronic kidney disease:: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality
Mengli Tong et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps
Sebastien Jaillon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The long pentraxin PTX3 in vascular pathology
Alberto Mantovani et al.
VASCULAR PHARMACOLOGY (2006)
Regression of Atherosclerosis by Amlodipine via Anti-Inflammatory and Anti-Oxidative Stress Actions
Toyofumi Yoshii et al.
HYPERTENSION RESEARCH (2006)
Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension
S Manabe et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Association of C-reactive protein with blood pressure and hypertension - Life course confounding and Mendelian randomization tests of causality
GD Smith et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients
R Marfella et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis
C Kataoka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence
LE Bautista
JOURNAL OF HUMAN HYPERTENSION (2003)
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis
S Navalkar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Preserving renal function in adults with hypertension and diabetes: A consensus approach
GL Bakris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction - Findings from National Health and Nutrition Examination Survey III
ES Ford et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)